Rodgers Brothers’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-29,321
Closed -$561K 238
2024
Q3
$561K Sell
29,321
-1,136
-4% -$23.5K 0.07% 173
2024
Q2
$630K Sell
30,457
-3,469
-10% -$68.9K 0.09% 164
2024
Q1
$638K Sell
33,926
-3,317
-9% -$56.9K 0.09% 161
2023
Q4
$537K Sell
37,243
-8,254
-18% -$112K 0.08% 165
2023
Q3
$790K Buy
45,497
+5,746
+14% +$120K 0.13% 127
2023
Q2
$827K Sell
39,751
-41,928
-51% -$911K 0.15% 122
2023
Q1
$1.92M Buy
81,679
+546
+0.7% +$14.7K 0.37% 73
2022
Q4
$2.27M Sell
81,133
-32,305
-28% -$826K 0.46% 64
2022
Q3
$2.65M Sell
113,438
-570
-0.5% -$17.2K 0.57% 56
2022
Q2
$3.85M Sell
114,008
-6,000
-5% -$210K 0.76% 40
2022
Q1
$4.19M Buy
120,008
+28,783
+32% +$984K 0.75% 39
2021
Q4
$2.78M Sell
91,225
-43,879
-32% -$1.43M 0.49% 56
2021
Q3
$4.43M Buy
135,104
+60,594
+81% +$1.94M 0.88% 35
2021
Q2
$2.25M Buy
+74,510
New +$2.45M 0.43% 67

Other funds holding OGN

Rodgers Brothers's OGN Position: Q4 2024 in Review

Rodgers Brothers sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 29,321 shares — an estimated $561K sold.

Rodgers Brothers first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $4.43M in Q3 2021. 739 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Rodgers Brothers reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Rodgers Brothers sold 29,321 Organon & Co shares in Q4 2024, an estimated $561K.
  • Rodgers Brothers first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
  • Rodgers Brothers's Organon & Co position peaked at $4.43M in Q3 2021.
  • 739 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Rodgers Brothers's 13F filing for Q4 2024, filed 12 Feb 2025.